Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
about
The European Hematology Association Roadmap for European Hematology Research: a consensus documentDelayed hemolytic transfusion reaction in sickle cell diseaseDelayed hemolytic transfusion reaction in children with sickle cell disease.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.Challenges of alloimmunization in patients with haemoglobinopathies.How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.An Attempt to Induce Transient Immunosuppression Pre-erythrocytapheresis in a Girl With Sickle Cell Disease, a History of Severe Delayed Hemolytic Transfusion Reactions and Need for Hip ProsthesisSuccessful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.Delayed hemolytic transfusion reaction, intravenous immunoglobulin, and rituximab.Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model.Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.
P2860
Q28830861-EC342395-621D-4637-86D7-1147F77D1733Q33724538-0C23B1A8-0E7E-4AD8-B804-873C7977DFBEQ35018501-F50A67EC-D45E-4963-A0BC-EA647BA8CAF7Q36106307-7272DEE6-9550-46ED-83CE-7D03FE6F9D71Q38049189-F741E35B-C11B-4BDF-9994-D1A437B29422Q38476241-FA054891-251B-4614-A1F9-FB562A6C22F3Q38949082-EB74D5A5-D4E7-4EFC-BFD1-5BD6A03C5DF5Q41272014-77F968D7-C9D0-486E-9E5E-3096511D4234Q41982475-A0CE9DA5-79FD-4299-A57C-9CE5B7D24AAAQ44980055-35F507D5-C6E4-433C-8D8E-3B3A10991DBDQ46141398-EA0BCDF7-6451-44E9-8F96-A0EF218E5DECQ46207877-4C5BB74D-988B-4854-8390-08E130C3BFDBQ47621588-CFF247CA-209E-415E-AA91-9F72382C569EQ50218898-4D781B19-5BD4-45C4-89F5-43BD68B4E265Q50241611-3AC5C001-51ED-45A0-8226-0F801CBC8558Q50445091-5FA9A026-0732-453B-B6DF-89055C450639Q50451822-788757B2-D6CC-4DE0-A2B3-8A9838FF73E6Q50454968-B47CB88E-D374-4732-BE45-1A8CE33ECC71Q51678751-18535F51-36C3-4265-89D2-7977AAFC156DQ53686375-698E24EA-EA04-4453-9DFA-055FBB1D7669Q55427971-087F3FA2-777B-49A1-A2C4-B93DF84F8FFA
P2860
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Rituximab for prevention of de ...... action in sickle cell disease.
@ast
Rituximab for prevention of de ...... action in sickle cell disease.
@en
Rituximab for prevention of de ...... action in sickle cell disease.
@nl
type
label
Rituximab for prevention of de ...... action in sickle cell disease.
@ast
Rituximab for prevention of de ...... action in sickle cell disease.
@en
Rituximab for prevention of de ...... action in sickle cell disease.
@nl
prefLabel
Rituximab for prevention of de ...... action in sickle cell disease.
@ast
Rituximab for prevention of de ...... action in sickle cell disease.
@en
Rituximab for prevention of de ...... action in sickle cell disease.
@nl
P2093
P356
P1433
P1476
Rituximab for prevention of de ...... action in sickle cell disease.
@en
P2093
Bierling P
Chadebech P
Galactéros F
Noizat-Pirenne F
Plonquet A
P304
P356
10.3324/HAEMATOL.12074
P577
2007-12-01T00:00:00Z